NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Menten AI

Menten AI

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://menten.ai/

Last Round

Seed

Jun 30, 2020

Est. Valuation

$2.14M

Total Funding Raised

$4.15M

Company Overview

Menten AI is a biotechnology company that develops generative AI and quantum computing technologies to design peptide macrocycles and proteins for therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Quantum Computing

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

cyclic peptide designdrug discovery platformAI drug discoveryquantum computingpreclinical drug discoverygenerative AIin silico drug designprotein-protein interactionsphysics-based modelingcomputational biologypeptide therapeuticsquantum drug discoverybiotech AIde novo designpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Menten AI Comparables

Compare Menten AI with similar companies based on industry and business-model similarity.

Menten AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vilya
87%
ProteinQure
87%
Ordaos Bio
87%

Menten AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 30, 2020
AcceleratorMar 18, 2020

Key People

Founding team and executive leadership

Hans Melo

Co-Founder And CEO

Founding Team

Menten AI Investors

Notable investors and investment history

Menten AI investors
InvestorRounds
Uncork CapitalSeed
Khosla VenturesSeed
Social Impact CapitalSeed
Y CombinatorSeed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Launched MAUD 1.0 for AI-driven design of cyclic peptide medicines.

  • Oct 1, 2025

    Collaboration to accelerate preclinical drug discovery efforts.

Menten AI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Menten AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Menten AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range19
Year Founded2018
Last FundingJun 30, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.